Article

Is There A Legislative Fix for Biotech Patents?

Intellectual Property Magazine

13 Apr 2017
Reprinted with permission.

Morrison & Foerster partner Matthew Kreeger and associate Christopher Jamieson Kendall authored “Is there a legislative fix for biotech patents?” for Intellectual Property Magazine. A string of Supreme Court of the United States rulings demonstrate a lack of patent protection for biotech inventions, and SCOTUS efforts to explain its long-held exceptions to Section 101 – laws of nature, physical phenomena, and abstract ideas – have created greater confusion and an increased number of ineligible patents. This article argues that a legislative fix may be the best remedy to the biotech patent issue.

Read the full Intellectual Property Magazine article.

Close
Feedback

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.